Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset

Annals of Neurology

Volumn 56, Issue 6, 2004, Pages 905-908

  Dauvilliers, Yves ^a,b,c   Carlander, Bertrand ^a   Rivier, François ^a   Touchon, Jacques ^a,c   Tafti, Mehdi ^b  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Montpellier 1 University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; OREXIN;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CATAPLEXY; DISEASE SEVERITY; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MALE; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD;

ADULT; CATAPLEXY; CHILD; DISEASE MANAGEMENT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; NARCOLEPSY; TIME FACTORS;

EID: 9644288106     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20339     Document Type: Article

References (14)

1. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
2. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-474.
3. Nishino S, Ripley B, Overeem S, et al. Hypocretin (otexin) deficiency in human narcolepsy. Lancet 2000;355.1:39-40.
4. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-1562.
5. Dauvilliers Y, Baumann CR, Catlander B, et al. CSF hypocretin 1 levels in narcolepsy, Kleine-Levin syndrome and other hypersomnia and neurological conditions. J Neurol Neurosurg Psychiatry 2003;74:1667-1673.
6. Mignot E, Lin L, Rogers W, et al. Complex HLA DR and DQ interactions confer risk of narcolepsy cataplexy in three ethnic groups. Am J Hum Genet 2001;68:686-699.
7. Dauvilliets Y, Montplaisit J, Molinati N, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001;57:2029-2033.
8. Orellana C, Villemin E, Tafti M, et al. Life events in the year preceding the onset of narcolepsy. Sleep 1994;17:50-53.
9. Kubota H, Kanbayashi T, Tanabe Y, et al. Decreased cerebrospinal fluid hypoctetin-1 levels near the onset of narcolepsy in 2 prepubertal children. Sleep 2003;26:555-557.
10. Tsukamoto H, Ishikawa T, Fujii Y, et al. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy. Neuropediatrics 2002;33:51-52
11. Hecht M, Lin L, Kushida CA, et al. Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin- deficiency narcolepsy. Sleep 2003;26:809-810.
12. Lecendreux M, Maret S, Basserri C, et al. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 2003;12:347-348.
13. Sangal RB, Thomas L, Mitler MM. Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders. Chest 1992;101:898-902.
14. Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 2004;291:2367-2375.